Introduction: Medical oxygen supplementation plays a very critical role in managing the patients affected with Covid-19. This COVID-19 disease is known to be caused by a virus named SARS-CoV-2 and the major symptoms include fever, cough and dyspnoea. Therefore, this study has been carried out to explore the requirement of oxygen therapy among covid-19 patients that were associated with dysgeusia and anosmia. Materials and Method: Out of 650 individuals suffering from acute respiratory illness examined, 500 people were tested positive and 150 stayed negative. All the details were efficiently collected from the patients files that include various clinical signs and symptoms related to acute respiratory illnesses. These signs and symptoms include their age, fever, headache, dry cough, fatigue, dysgeusia, anosmia, dyspnoea, diarrhoea and abdominal pain.Correlation of anosmia and dysgeusia with requirement of oxygen among covid-19 patients was analysed. Data were collected and analysed using SPSS software and simple frequencies of the data are presented as medians and the difference between the groups are evaluated by Mann-Whitney U test. Results: Anosmia and dysgeusia was present in 247 and 253 covid 19 positive cases which accounts to 44% and 46 % cases respectively which was statistically significant among covid-19 symptoms. 3 % of patients with anosmia and 4% patients with dysgeusia among COVID -19 cases required oxygen therapy which was statistically insignificant. All Patients presenting with anosmia and dysgeusia as covid 19 symptoms had good prognosis and majority were treated with home isolation. Conclusion: In this study, the requirement of oxygen in COVID -19 patients having symptoms of anosmia and dysgeusia was statistically insignificant and the disease in such patients had better prognosis.